Related Experiment Video
Updated: Feb 13, 2026
04:01
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
1.5K
Summary
Statins offer life-saving benefits but carry risks. Statin side effects like myalgia and rhabdomyolysis are manageable, with immune-mediated myopathy requiring immunosuppression alongside statin withdrawal.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Safety
Background:
- Statins are widely prescribed cholesterol-lowering drugs with debated risk-benefit profiles.
- Adverse effects range from common myalgia to rare but severe rhabdomyolysis and immune-mediated myopathy.
Purpose of the Study:
- To review the spectrum of statin-induced muscle-related side effects.
- To discuss the clinical presentation, management, and underlying mechanisms of these adverse events.
Main Methods:
- Literature review of statin-induced myopathy, rhabdomyolysis, and immune-mediated necrotising myopathy.
- Analysis of clinical data and proposed pathomechanisms.
Main Results:
- Statin-induced myalgia is common, usually mild, and responsive to dose adjustment or discontinuation.
- Rhabdomyolysis, often linked to drug interactions, is rare but clinically significant due to widespread statin use.
- Immune-mediated necrotising myopathy is a distinct entity requiring immunosuppression and statin withdrawal for resolution.
Conclusions:
- Statin therapy presents a complex balance of benefits and risks.
- Understanding and managing muscle-related side effects is crucial for patient safety and treatment adherence.
- Novel mechanisms like immune-mediated myopathy highlight the need for continued research into statin adverse effects.
Keywords:
myopathy
